Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
11,04 USD | -4,46% |
|
-1,61% | -9,96% |
Attività
Numero di dipendenti: 118
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 26/03/04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01/08/16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 03/05/21 |
Ryan Baker
IRC | Investor Relations Contact | - | 01/05/23 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 25/07/23 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 01/11/16 |
Mike Smith
PRN | Corporate Officer/Principal | - | 01/02/16 |
Rachel Morten
LAW | General Counsel | - | 01/01/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 01/02/19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01/08/16 |
Albert Cha
BRD | Director/Board Member | 51 | 01/01/16 |
Edward Unkart
BRD | Director/Board Member | 74 | 01/12/14 |
Nancy Stuart
BRD | Director/Board Member | 65 | 18/03/21 |
Patrick Treanor
BRD | Director/Board Member | - | 26/05/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 42 188 296 | 41 670 541 ( 98,77 %) | 0 | 98,77 % |
Coordinate società
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.com![Indirizzo KalVista Pharmaceuticals, Inc.(KALV)](https://cdn.zonebourse.com/static/address/32018912.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-9,96% | 487 Mln | |
+2,87% | 94,22 Mrd | |
-4,08% | 37,76 Mrd | |
-13,90% | 32,5 Mrd | |
+73,38% | 27,75 Mrd | |
-12,13% | 16,13 Mrd | |
-1,19% | 14,19 Mrd | |
-11,67% | 11,42 Mrd | |
+190,36% | 11,06 Mrd | |
-52,61% | 9,09 Mrd |
- Borsa valori
- Azioni
- Azione KALV
- Società KalVista Pharmaceuticals, Inc.